Harbin Pharmaceutical Group Co Ltd (600664) — Cash Flow Reinvestment Rate
Harbin Pharmaceutical Group Co Ltd (600664) has a Cash Flow Reinvestment Rate of 0.12x as of June 2025, reinvesting CN¥38.54 Million (capex CN¥20.49 Million plus investments CN¥-18.05 Million) from operating cash flow of CN¥323.33 Million. Explore how much does Harbin Pharmaceutical Group Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Harbin Pharmaceutical Group Co Ltd across 23 annual periods. Also explore 600664 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Harbin Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see how much is Harbin Pharmaceutical Group Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥101.52 Million | CN¥792.50 Million | CN¥100.81 Million | ▲ +39.6% |
| 2023 | 0.09x | CN¥87.12 Million | CN¥949.67 Million | CN¥86.54 Million | ▼ -64.8% |
| 2022 | 0.26x | CN¥161.98 Million | CN¥622.09 Million | CN¥89.65 Million | ▼ -77.6% |
| 2018 | 1.16x | CN¥806.46 Million | CN¥692.72 Million | CN¥114.11 Million | ▲ +31.6% |
| 2017 | 0.88x | CN¥132.01 Million | CN¥149.22 Million | CN¥102.01 Million | ▲ +1236.9% |
| 2016 | 0.07x | CN¥183.82 Million | CN¥2.78 Billion | CN¥107.46 Million | ▼ -65.8% |
| 2015 | 0.19x | CN¥320.75 Million | CN¥1.66 Billion | CN¥290.75 Million | ▼ -41.5% |
| 2014 | 0.33x | CN¥375.37 Million | CN¥1.14 Billion | CN¥375.37 Million | ▼ -87.3% |
| 2013 | 2.61x | CN¥369.90 Million | CN¥141.64 Million | CN¥369.90 Million | ▲ +428.2% |
| 2012 | 0.49x | CN¥275.78 Million | CN¥557.83 Million | CN¥275.78 Million | ▲ +90.5% |
| 2010 | 0.26x | CN¥299.19 Million | CN¥1.15 Billion | CN¥299.19 Million | ▲ +115.3% |
| 2009 | 0.12x | CN¥223.26 Million | CN¥1.85 Billion | CN¥223.26 Million | ▼ -51.2% |
| 2008 | 0.25x | CN¥143.09 Million | CN¥578.59 Million | CN¥143.09 Million | ▼ -8.1% |
| 2007 | 0.27x | CN¥175.00 Million | CN¥650.16 Million | CN¥175.00 Million | ▼ -39.1% |
| 2006 | 0.44x | CN¥326.28 Million | CN¥738.08 Million | CN¥326.28 Million | ▼ -24.5% |
| 2005 | 0.59x | CN¥443.61 Million | CN¥757.76 Million | CN¥443.61 Million | ▼ -79.6% |
| 2004 | 2.88x | CN¥428.60 Million | CN¥149.01 Million | CN¥428.60 Million | ▲ +83.9% |
| 2003 | 1.56x | CN¥473.73 Million | CN¥302.83 Million | CN¥473.73 Million | ▲ +53.4% |
| 2002 | 1.02x | CN¥391.03 Million | CN¥383.44 Million | CN¥391.03 Million | ▼ -3.0% |
| 2001 | 1.05x | CN¥635.28 Million | CN¥604.13 Million | CN¥635.28 Million | ▼ -2.2% |
| 2000 | 1.08x | CN¥582.49 Million | CN¥541.70 Million | CN¥582.49 Million | ▲ +151.4% |
| 1999 | 0.43x | CN¥184.43 Million | CN¥431.22 Million | CN¥184.43 Million | ▼ -6.0% |
| 1998 | 0.45x | CN¥100.73 Million | CN¥221.41 Million | CN¥100.73 Million | — |